Health and Healthcare

AstraZeneca : AZN

All AstraZeneca Articles

218 Articles

Jon C. Ogg | Apr 21, 2014 at 1:25 PM EDT

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

ThinkstockIt is not that common that you hear about mergers in the $50 billion range. But what about when you…

Jon C. Ogg | Mar 3, 2014 at 8:20 AM EST

Top Analyst Upgrades and Downgrades: Apple, MarkWest, NII Holdings, RF Micro, SodaStream and More

These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on Monday, March 3, 2014.…

Jon C. Ogg | Nov 19, 2013 at 12:30 PM EST

Horizon Pharma Deal Ramps Up Profitability Timeline

ThinkstockHorizon Pharma Inc. (NASDAQ: HZNP) is having a stellar day after breaking news that it entered into a pact with…

Douglas A. McIntyre | Oct 2, 2013 at 6:30 AM EDT

Big Pharma and 100,000 Jobs at Risk

ThinkstockMerck & Co. (NYSE: MRK) announced it would rid itself of 8,500 workers, many of whom work in the big…

Lee Jackson | Sep 16, 2013 at 8:45 AM EDT

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

ThinkstockInvestors make big money in biotechnology stocks when they focus on areas that cut across a wide swath of the…

Trey Thoelcke | Sep 13, 2013 at 8:50 AM EDT

UBS Offers Eight Well-Known International Large Cap Dividend Ruler Stocks

ThinkstockWith yields on 10-year Treasury bonds up nearly 1.5% since early May and briefly touching 3.0% last week, the impact…

Jon C. Ogg | Aug 15, 2013 at 8:30 AM EDT

Top Analyst Upgrades and Downgrades: Carnival, Intel, Micron, Pulte and More

Jon OggInvestors are on the hunt for solid research ideas now that stocks have pulled back a bit. 24/7 Wall…

Paul Ausick | Jul 2, 2013 at 7:35 AM EDT

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

ThinkstockAlthough Amgen Inc.’s (NASDAQ: AMGN) $10 billion offer for Onyx Pharmaceuticals Inc. (NASDAQ: ONXX) was unsolicited and not exactly a…

Jon C. Ogg | Jun 17, 2013 at 8:10 AM EDT

UBS Dividend Ruler Stocks Combine Solid Yield and Growth Prospects

ThinkstockOver the past five weeks, the 10-year Treasury bond yield has increased by over one-half of one percent from 1.66%…

Paul Ausick | Jun 4, 2013 at 4:06 PM EDT

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Sink Later

U.S. equity markets opened slightly higher this morning but lost steam in the afternoon to finish with a loss for…

Jon C. Ogg | May 9, 2013 at 8:35 AM EDT

UBS Offers Global Dividend Ruler Stocks to Buy: Total, Teva, TD and More

ThinkstockTotal return is always the name of the game when it comes to investing success. Stocks that pay dividends on…

Jon C. Ogg | May 6, 2013 at 10:45 AM EDT

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

ThinkstockThe world of pharmaceuticals may have faced a patent cliff in recent years, but brand name drugs are still generating…

Jon C. Ogg | Apr 9, 2013 at 8:40 AM EDT

UBS Has Top Dividend Ruler Stocks From Around the World (AZN, TOT, INTC, BNS, NU, SNY, OXY, UPS, JNJ, CLX)

ThinkstockInvestors love dividends, and this component of investing plays a very important part of the total return through time. Buying…

Jon C. Ogg | Mar 28, 2013 at 9:45 AM EDT

Top Key Call Stocks From UBS Global Ideas of the Week (LOW, TWX, BUD, APC, KEY, AZN, RIO, UBS)

When the holidays wound down and we started off 2013, all the Wall St. firms started to put out their…

Paul Ausick | Mar 5, 2013 at 7:55 AM EST

J&J, Bayer Fail to Gain FDA Approval for Blood Thinner

ThinkstockThe U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany’s…

1 … 8 9 10 11 12 … 15

AstraZeneca : AZN

All AstraZeneca Articles

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

Top Analyst Upgrades and Downgrades: Apple, MarkWest, NII Holdings, RF Micro, SodaStream and More

Horizon Pharma Deal Ramps Up Profitability Timeline

Big Pharma and 100,000 Jobs at Risk

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

UBS Offers Eight Well-Known International Large Cap Dividend Ruler Stocks

Top Analyst Upgrades and Downgrades: Carnival, Intel, Micron, Pulte and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

UBS Dividend Ruler Stocks Combine Solid Yield and Growth Prospects

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Sink Later

UBS Offers Global Dividend Ruler Stocks to Buy: Total, Teva, TD and More

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

UBS Has Top Dividend Ruler Stocks From Around the World (AZN, TOT, INTC, BNS, NU, SNY, OXY, UPS, JNJ, CLX)

Top Key Call Stocks From UBS Global Ideas of the Week (LOW, TWX, BUD, APC, KEY, AZN, RIO, UBS)

J&J, Bayer Fail to Gain FDA Approval for Blood Thinner

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s

MISL Investors: Watch the FY27 Budget Bill Before the Next Rally

Fed’s Rate Freeze Could Sting for Social Security Recipients

AstraZeneca : AZN

All AstraZeneca Articles

What a Combined Pfizer and AstraZeneca Would Look Like, and Face

Top Analyst Upgrades and Downgrades: Apple, MarkWest, NII Holdings, RF Micro, SodaStream and More

Horizon Pharma Deal Ramps Up Profitability Timeline

Big Pharma and 100,000 Jobs at Risk

Wall Street Sees Big Biotech Making Tens of Billions in Two Critical Areas

UBS Offers Eight Well-Known International Large Cap Dividend Ruler Stocks

Top Analyst Upgrades and Downgrades: Carnival, Intel, Micron, Pulte and More

Drugmakers Pfizer, Bayer, Novartis May Join Bidding for Onyx

UBS Dividend Ruler Stocks Combine Solid Yield and Growth Prospects

Closing Bell for Tuesday on Wall Street: Markets Open Higher, Sink Later

UBS Offers Global Dividend Ruler Stocks to Buy: Total, Teva, TD and More

The Top Seven Drugs with U.S. Quarterly Sales Over $1 Billion

UBS Has Top Dividend Ruler Stocks From Around the World (AZN, TOT, INTC, BNS, NU, SNY, OXY, UPS, JNJ, CLX)

Top Key Call Stocks From UBS Global Ideas of the Week (LOW, TWX, BUD, APC, KEY, AZN, RIO, UBS)

J&J, Bayer Fail to Gain FDA Approval for Blood Thinner

Fed’s Rate Freeze Could Sting for Social Security Recipients

‘Convert $100,000 a Year to Get Them to the Top of the 22%’: The Roth Plan for a Couple With $2.3M in 401(k)s

UFO ETF Faces a Critical Test: Can Pre-Profit Space Stocks Deliver on $1.85B Backlog

Featured Reads

Fed’s Rate Freeze Could Sting for Social Security Recipients

'Convert $100,000 a Year to Get Them to the Top of the 22%': The Roth Plan for a Couple With $2.3M in 401(k)s